Torii Pharmaceutical Co Ltd
TSE:4551
Torii Pharmaceutical Co Ltd
Interest Income Expense
Torii Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Torii Pharmaceutical Co Ltd
TSE:4551
|
Interest Income Expense
¥575m
|
CAGR 3-Years
43%
|
CAGR 5-Years
41%
|
CAGR 10-Years
29%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥161.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥25.6B
|
CAGR 3-Years
136%
|
CAGR 5-Years
47%
|
CAGR 10-Years
96%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥30.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥3.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
-¥3.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
See Also
What is Torii Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
575m
JPY
Based on the financial report for Dec 31, 2023, Torii Pharmaceutical Co Ltd's Interest Income Expense amounts to 575m JPY.
What is Torii Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
29%
Over the last year, the Interest Income Expense growth was 89%. The average annual Interest Income Expense growth rates for Torii Pharmaceutical Co Ltd have been 43% over the past three years , 41% over the past five years , and 29% over the past ten years .